BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3754025)

  • 1. Hypercalcemia and elevated serum 1,25-dihydroxyvitamin D3 in a patient with Hodgkin's lymphoma.
    Schaefer K; Saupe J; Pauls A; von Herrath D
    Klin Wochenschr; 1986 Jan; 64(2):89-91. PubMed ID: 3754025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humoral hypercalcemia in Hodgkin's disease. Association with elevated 1,25-dihydroxycholecalciferol levels and subperiosteal bone resorption.
    Zaloga GP; Eil C; Medbery CA
    Arch Intern Med; 1985 Jan; 145(1):155-7. PubMed ID: 3838228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypercalcemia in hyperthyroidism: patterns of serum calcium, parathyroid hormone, and 1,25-dihydroxyvitamin D3 levels during management of thyrotoxicosis.
    Iqbal AA; Burgess EH; Gallina DL; Nanes MS; Cook CB
    Endocr Pract; 2003; 9(6):517-21. PubMed ID: 14715479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypercalcemia associated with increased serum calcitriol levels in three patients with lymphoma.
    Breslau NA; McGuire JL; Zerwekh JE; Frenkel EP; Pak CY
    Ann Intern Med; 1984 Jan; 100(1):1-6. PubMed ID: 6546327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parathyroid-hormone-related peptide in hematologic malignancies.
    Kremer R; Shustik C; Tabak T; Papavasiliou V; Goltzman D
    Am J Med; 1996 Apr; 100(4):406-11. PubMed ID: 8610726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcitriol production in hypercalcemic and normocalcemic patients with non-Hodgkin lymphoma.
    Seymour JF; Gagel RF; Hagemeister FB; Dimopoulos MA; Cabanillas F
    Ann Intern Med; 1994 Nov; 121(9):633-40. PubMed ID: 7944070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary hyperparathyroidism and severe hypercalcemia with low circulating 1,25-dihydroxyvitamin D.
    Shaker JL; Krawczyk KW; Findling JW
    J Clin Endocrinol Metab; 1990 Nov; 71(5):1305-9. PubMed ID: 2229288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case report: hypercalcemia with inappropriate 1,25-dihydroxyvitamin D in Wegener's granulomatosis.
    Shaker JL; Redlin KC; Warren GV; Findling JW
    Am J Med Sci; 1994 Aug; 308(2):115-8. PubMed ID: 8042652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From hypocalcemia to hypercalcemia-an unusual clinical presentation of a patient with permanent postsurgical hypoparathyroidism.
    Sundaresh V; Levine SN
    J Clin Endocrinol Metab; 2015 Jan; 100(1):21-4. PubMed ID: 25303492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of pulmonary sarcoidosis associated with severe hypercalcemia].
    Shinozaki K; Koya D; Sakamoto K; Kashiwagi A; Yamamoto I; Kikkawa R; Shigeta Y
    Nihon Naibunpi Gakkai Zasshi; 1994 Jun; 70(5):503-10. PubMed ID: 7958099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sarcoidosis initially manifesting as symptomatic hypercalcemia with the absence of organic involvement.
    Motoyama K; Inaba M; Emoto M; Morii H; Nishizawa Y
    Intern Med; 2002 Jun; 41(6):449-52. PubMed ID: 12135177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hodgkin's disease with hypercalcemia detected by thallium-201 scintigraphy.
    Linde R; Basso L
    J Nucl Med; 1987 Jan; 28(1):112-5. PubMed ID: 3025384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketoconazole decreases the serum ionized calcium and 1,25-dihydroxyvitamin D levels in tuberculosis-associated hypercalcemia.
    Saggese G; Bertelloni S; Baroncelli GI; Di Nero G
    Am J Dis Child; 1993 Mar; 147(3):270-3. PubMed ID: 8438806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ketoconazole reduces elevated serum levels of 1,25-dihydroxyvitamin D in hypercalcemic sarcoidosis.
    Glass AR; Cerletty JM; Elliott W; Lemann J; Gray RW; Eil C
    J Endocrinol Invest; 1990 May; 13(5):407-13. PubMed ID: 2166103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idiopathic infantile hypercalcemia: rapid response to treatment with calcitonin.
    Alon U; Berkowitz D; Berant M
    Child Nephrol Urol; 1992; 12(1):47-50. PubMed ID: 1606583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal calcium metabolism caused by increased circulating 1,25-dihydroxyvitamin D in a patient with rheumatoid arthritis.
    Gates S; Shary J; Turner RT; Wallach S; Bell NH
    J Bone Miner Res; 1986 Apr; 1(2):221-6. PubMed ID: 3503540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible hypocalciuric hypercalcemia associated with hypothyroidism.
    Zaloga GP; Eil C; O'Brian JT
    Am J Med; 1984 Dec; 77(6):1101-4. PubMed ID: 6548873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased serum level of 1,25-dihydroxyvitamin D3 after parathyroid hormone in the normocalcemic phase of idiopathic hypercalcemia.
    Pronicka E; Kulczycka H; Lorenc R; Prószyńska K; Gradzka J; Rowińska E
    J Pediatr; 1988 Jun; 112(6):930-3. PubMed ID: 3373402
    [No Abstract]   [Full Text] [Related]  

  • 19. Elevations in circulating 1,25-dihydroxyvitamin D in three patients with lymphoma-associated hypercalcemia.
    Rosenthal N; Insogna KL; Godsall JW; Smaldone L; Waldron JA; Stewart AF
    J Clin Endocrinol Metab; 1985 Jan; 60(1):29-33. PubMed ID: 3871092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parathyroid hormone-related protein as a cause of hypercalcemia in a B-cell type malignant lymphoma.
    Wada S; Kitamura H; Matsuura Y; Katayama Y; Ohkawa H; Kugai N; Motoyoshi K; Fuse Y; Nagata N
    Intern Med; 1992 Aug; 31(8):968-72. PubMed ID: 1335805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.